137 related articles for article (PubMed ID: 34541940)
21. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma.
Gerami P; Jewell SS; Pouryazdanparast P; Wayne JD; Haghighat Z; Busam KJ; Rademaker A; Morrison L
J Mol Diagn; 2011 May; 13(3):352-8. PubMed ID: 21497295
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence in situ hybridisation (FISH) in histologically challenging conjunctival melanocytic lesions.
Mudhar HS; Smith K; Talley P; Whitworth A; Atkey N; Rennie IG
Br J Ophthalmol; 2013 Jan; 97(1):40-6. PubMed ID: 23137666
[TBL] [Abstract][Full Text] [Related]
23. Clear cell melanoma: a cutaneous clear cell malignancy.
Pletneva MA; Andea A; Palanisamy N; Betz BL; Carskadon S; Wang M; Patel RM; Fullen DR; Harms PW
Arch Pathol Lab Med; 2014 Oct; 138(10):1328-36. PubMed ID: 25268196
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 homogeneous staining regions by fluorescent in situ hybridization: a possible indicator of aggressive behavior in melanomas.
Gerami P; Guitart J; Martini M; Wayne JD; Kuzel T
Arch Dermatol; 2008 Sep; 144(9):1235-6. PubMed ID: 18794480
[No Abstract] [Full Text] [Related]
25. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
[TBL] [Abstract][Full Text] [Related]
27. The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma.
Kaufmann C; Kempf W; Mangana J; Cheng P; Emberger M; Lang R; Kaiser AK; Lattmann E; Levesque M; Dummer R; Koelblinger P
Histopathology; 2020 Sep; 77(3):460-470. PubMed ID: 32374893
[TBL] [Abstract][Full Text] [Related]
28. An update on the implications of cyclin D1 in melanomas.
González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ayén Á; Ramos-García P
Pigment Cell Melanoma Res; 2020 Nov; 33(6):788-805. PubMed ID: 32147907
[TBL] [Abstract][Full Text] [Related]
29. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
Utikal J; Udart M; Leiter U; Peter RU; Krähn G
Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
[TBL] [Abstract][Full Text] [Related]
30. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
[TBL] [Abstract][Full Text] [Related]
31. [Fluorescence in-situ hybridization as a diagnostic tool for cutaneous melanoma].
Su J; Liu J; Zheng J; You J; Ma X; Zhang Y; Zhang J; Liao S
Zhonghua Bing Li Xue Za Zhi; 2015 Jan; 44(1):37-41. PubMed ID: 25765029
[TBL] [Abstract][Full Text] [Related]
32. Gain of CCND1 May Occur Too Infrequently in Cutaneous Melanoma, and Too Late in Melanomagenesis, to Be Diagnostically Useful: Genomic Analysis of 88 Cases.
McFadden JR; Chaudhari AS; Stevanovic M; Tsongalis GJ; Hughes EG; Sriharan A
Am J Dermatopathol; 2023 May; 45(5):311-319. PubMed ID: 36939129
[TBL] [Abstract][Full Text] [Related]
33. [Molecular genetic study of benign pigmented neoplasms by fluorescence in situ hybridization].
Senderovich AI; Stroganova AM; Piatnitskiĭ MA; Vishnevskaia IaV; Karseladze AI
Arkh Patol; 2010; 72(4):27-30. PubMed ID: 21086634
[TBL] [Abstract][Full Text] [Related]
34. An unusual case of desmoplastic melanoma containing an osteoclast-like giant cell-rich nodule.
Houang M; Castillo C; La Marca S; Combemale P; Wang Q; Paindavoine S; Pissaloux D; de la Fouchardiere A
Am J Dermatopathol; 2015 Apr; 37(4):299-304. PubMed ID: 24999544
[TBL] [Abstract][Full Text] [Related]
35. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
36. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
37. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
Palla B; Su A; Binder S; Dry S
Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
[TBL] [Abstract][Full Text] [Related]
38. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations.
Gerami P; Scolyer RA; Xu X; Elder DE; Abraham RM; Fullen D; Prieto VG; Leboit PE; Barnhill RL; Cooper C; Yazdan P; Guitart J; Liu P; Pestova E; Busam K
Am J Surg Pathol; 2013 May; 37(5):676-84. PubMed ID: 23388126
[TBL] [Abstract][Full Text] [Related]
39. The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
Vízkeleti L; Ecsedi S; Rákosy Z; Orosz A; Lázár V; Emri G; Koroknai V; Kiss T; Ádány R; Balázs M
Tumour Biol; 2012 Dec; 33(6):2189-99. PubMed ID: 23001925
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
